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White-nose syndrome (WNS) is a fungal disease responsible for decimating
many bat populations in North America. Pseudogymnoascus destructans (Pd),
the psychrophilic fungus responsible for WNS, prospers in the winter habitat
of many hibernating bat species. The immune response that Pd elicits in bats
is not yet fully understood; antibodies are produced in response to infection
by Pd, but they may not be protective and indeed may be harmful. To under-
stand how bats respond to infection during hibernation, we studied the
effect of Pd inoculation on the survival and gene expression of captive hiber-
nating Myotis lucifugus with varying pre-hibernation antifungal antibody
titres. We investigated gene expression through the transcription of selected
cytokine genes (Il6, Il17a, Il1b, Il4 and Ifng) associated with inflammatory,
Th1, Th2 and Th17 immune responses in wing tissue and lymph nodes.
We found no difference in survival between bats with low and high anti-
Pd titres, although anti-Pd antibody production during hibernation differed
significantly between infected and uninfected bats. Transcription of Il6 and
Il17a was higher in the lymph nodes of infected bats compared with unin-
fected bats. Increased transcription of these cytokines in the lymph node
suggests that a pro-inflammatory immune response to WNS is not restricted
to infected tissues and occurs during hibernation. The resulting Th17
response may be protective in euthermic bats, but because it may disrupt
torpor, it could be detrimental during hibernation.
1. Introduction
The emergence of a new diseasemost frequently results from a change in the ecol-
ogy of the host, pathogen or environment, or an interaction of all three [1]. A
classic tenet of disease ecology is that disease is not simply a factor of the host’s
resilience and resistance, but rather occurs at the intersection of host dynamics,
properties of the pathogen and environmental conditions (i.e. the disease triangle)
[2]. White-nose syndrome (WNS), the epizootic disease caused by a fungus, has
killed millions of North American bats since 2007 [3]. In what is often described
as a ‘perfect storm’, WNS is deadly due to the negative synergism among sus-
ceptible hosts (hibernating bats) that have limited opportunity to respond to
infections during hibernation, a cold-loving fungal pathogen Pseudogymnoascus
destructans (hereafter Pd) that invades and destroys the skin, and the
cool, humid environment in which the host and pathogen reside [4–6]. While
Palaearctic bats in Europe and Asia have probably coexisted with Pd for several
thousand years [7,8], the fungus has only recently spread to North America via
anthropogenic introduction, causing mass mortality. Predictions of regional or
range-wide extinction of once common species highlight the need to understand
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the mechanisms behind survival and mortality of North
American bats infected with Pd [9].
A comprehensive understanding of the physiological
responses of the host is pivotal to decoding the factors contri-
buting to WNS. In general, fungal species are unable to cause
severe diseases in mammals due to the high body temperature
and effective immune system of the host [10]. However, Pd is
successful at invading the epidermis and adnexa of many
North American bats because infection occurs during hiber-
nation, when body temperature is significantly lowered [11]
and some immune responses are presumably downregulated
[12]. Infection causes cupping erosions on wing membranes,
muzzles and ears [13]. The invasive cutaneous mycosis [14]
causes alterations in hibernating behaviour [5,15,16], physi-
ology [17–19] and immune function [20]. These result in
increased frequency of arousals from hibernation in WNS-
affected little brown myotis (Myotis lucifugus) [16,21] and
cause mortality by depleting the fat reserves necessary for
survival before winter is over [5,15].
Hosts must mount an appropriate immune response to
pathogens to avoid reductions in fitness or survival rates. In
a previous study, we found that little brown myotis affected
by WNS detect fungal infection within epidermal tissue and
activate an innate immune response that includes local
inflammation [20]. To generate the appropriate adaptive
response, antigens should then be transmitted by activated
dendritic cells to the regional lymph node where inflamma-
tory cytokines should help generate an appropriate T-cell
response. One possible outcome is a humoral adaptive
response involving the selection and activation of B cells to
generate antibodies specific to fungal antigens. Antibodies
that can bind to Pd have been detected in North American
and European species of bats [22], suggesting a humoral
immune response might be used during fungal infection.
However, we found that although North American and Euro-
pean bat species in the wild vary in their levels of antibodies
that recognize Pd, titres do not correlate with either protection
or susceptibility to WNS [23]. We have also shown that some
North American bats that had not yet been exposed to Pd
have antibodies that are cross-reactive to Pd [22], presumably
stimulated in response to another fungus. By contrast, some
European bats appear to have relatively low levels of anti-
Pd antibodies despite endemic Pd exposure, suggesting that
their low antibody titres are beneficial and that a significant
humoral responses to Pd may indeed be maladaptive [22].
We propose that the limited resources available to mount
an immune response during hibernation represent a bottleneck
to WNS survival. Antibody-mediated responses to fungal
pathogens are more often associated with immune pathology
instead of protection [24]. Conversely, other T-cell-mediated
immune responses are more typically associated with control-
ling fungal infections in humans and other mammals [23].
These adaptive immune responses are regulated by the cyto-
kines produced by different subsets of T cells. Antibody
responses are driven by T helper 2 (Th2) immune responses,
including the cytokine interleukin 4 (IL-4) [25], but protective
antifungal immune responses are more likely to be driven by
different T-cell subsets, either Th1 or Th17 cells [26,27]. The
cytokines interleukin 6 (IL-6) and interleukin 17A (IL-17A),
produced by Th17 cells, are keymediators of antifungal immu-
nity, at least in most tissues in humans and mice [28]. Thus,
understanding host immune response to pathogens involves
both identifying the type of immune responses exhibited in
an infected population, as well as experimentally evaluating
the physiological consequences of those responses.
Because mounting an appropriate immune response to
fungal pathogens is important to host survival, the downre-
gulation of immune function during the hibernation period
has been cited as playing a major role in WNS [13]. Suppres-
sion of certain immune responses is seen as a major
physiological trade-off of torpor [12], and has been clearly
demonstrated for antibody responses to T-cell-dependent
antigens, but not T-cell-independent antigens, in hibernating
13-lined ground squirrels [29]. Antibody responses to the Pd
cell wall are likely to be T-cell independent [30] and we
wanted to test whether hibernation prevents the amplifica-
tion of this response in bats. Our previous work has shown
that hibernation does not prevent inflammatory responses
to Pd in the infected tissue [20]. However, it is not known
whether that inflammatory response can be transmitted to
the local lymphoid tissue during hibernation and whether
it can generate an appropriate adaptive response regionally.
We wanted to test whether the cytokine expression that
we had previously detected in the infected tissue (including
IL-6, IL-23 and IL-17C) [20] generated the expected antifungal
Th17 response in the regional lymphoid tissue.
We tested the hypothesis that anti-Pd humoral responses
may result in differences in susceptibility to WNS by being
either harmful or protective. Bats with higher titres may be
pre-disposed to a humoral response to Pd, at the expense of
a response that is more likely to be protective. We also further
studied responses to Pd-infection during hibernation by look-
ing at the expression of inflammatory and immunoregulatory
cytokines associated with Th1, Th2 and Th17 responses in
two relevant tissues: the wing tissue, showing responses at
the site of infection, and the axillary lymph nodes that
drain the wing tissue, where adaptive immune responses to
the infection will be coordinated. We predicted that
(i) infected bats with high pre-hibernation anti-Pd titres will
exhibit lower survival compared with infected bats with
low titre. We also predicted that (ii) infected bats with high
titres will have a greater Th2 than Th1 or Th17 signature com-
pared with bats with low titres and (iii) hibernation will not
prevent the amplification of a humoral response or the gener-
ation of a Th1, Th2 or Th17 response in the regional lymph
node.
2. Material and methods
(a) Bat capture and sampling protocols
We established a captive population of M. lucifugus naive to Pd
in August 2014, with bats caught during swarming at a major
hibernaculum in Greenland, MI, USA. After capture with harp
traps, bats were sexed, aged ( juvenile/adult), weighed and
banded. Wings were swabbed with dry cotton swabs for analysis
by quantitative-PCR (qPCR) to confirm negative Pd-status [31].
After swabbing, bats were placed in individual cheesecloth
bags and transported to Bucknell University. After 4 days of
acclimatization, we punctured a vein in the uropatagium (tail
wing membrane) using a 27.5-gauge sterile needle [32] and col-
lected blood into heparinized, microhematocrit, capillary tubes
(Kimball Chase Life Science, Vineland, NJ, USA). The contents
of the capillary tubes were immediately centrifuged to separate
plasma from blood cells; plasma was flash frozen and stored at
–808C. Titres of anti-Pd antibody were measured in triplicate
following Johnson et al. [22].
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(b) Experimental hibernation procedures
Based upon measured anti-Pd antibody titres, we placed bats into
one of two treatment groups—high (mean 43.0+96.3) or low titre
(mean 10.0+0.6)—which were further subdivided into control
and infected groups resulting in four groups for the experiment:
(i) high infected, (ii) low infected, (iii) high control and (iv) low con-
trol. Two replicate cages were used for each treatment. To the
extent possible, we randomly selected an equal number of males
and females to be placed into each treatment group (n ¼ 14–15
bats per group) with a matching distribution of body masses in
each group. To assess hibernation behaviour, a temperature data
logger (WeeTag, Alpha Mach Inc, Ste-Julie, QC, Canada) was
attached with a bonding agent (Torbot, Cranston, RI, USA) after
hair between the shoulder blades was trimmed. Loggers recorded
skin temperature (Tsk) every 10 min. Each batwas then either sham
inoculated (control groups) with 50 ml of phosphate-buffered
saline with 0.05% Tween-20 (PBST) or inoculated (infected
groups) with 5000 conidia of Pd, suspended in 50 ml PBST [31].
The solution was dispensed onto the ventral surface of one
wing below the wrist, and distributed along the wing by gentle
manipulation of the wing [21,22,31].
All infected bats were inoculated, temperature loggers were
attached and animals were placed into low-temperature environ-
mental chambers (Percival model no. I36VLC8) on 26 September
2014. Bats in each treatment group were housed in separate,
open-air, aluminium cages (two cages per treatment; Zoo Med
Laboratories, San Luis Obispo, CA, USA). Cage effect did not con-
found themain effects in the statisticalmodels, andwewere able to
use individual bats as experimental units for our analyses. Each
cage was provided with ad libitum water and placed into environ-
mental chambers set to maintain a constant temperature of 48C and
greater than or equal to 90% relative humidity. Control and inocu-
lated treatments were housed in separate environmental
chambers, with replicates of each treatment housed in the same
chamber, to ensure that no Pd transmission can occur between
cages.Moreover, cageswere not in contact, alsopreventingPd trans-
mission between cages [4]. Data loggers recording temperature and
relative humidity (TransiTemp II, MadgeTech, Warner, NH, USA)
were placed inside each environmental chamber to confirmenviron-
mental conditions. To avoid disturbance and unnatural arousals
from hibernation, chambers were opened to provide freshwater
and remove moribund bats only once every three weeks. Activity
of bats during hibernation was monitored with infrared cameras
placed inside the chambers.
(c) Post-hibernation procedures
At 16 weeks post-exposure (3 February 2015), we sampled the sur-
viving bats. Cages were removed from environmental chambers
20 min prior to the start of euthanasia to allow all animals to
rewarm from torpor and reach euthermic body temperature.
For each individual, time between removal of cage from the
chamber and the time that a bat was euthanized was recorded
(range ¼ 20–118 min, mean ¼ 69 min). Individual bats were
removed from their cage and immediately swabbed on the wing
tissue for qPCR analysis identifying DNA from Pd, and the
wings were photographed with UV transillumination to assess
the intensity of infection with Pd [33]. We then recorded mass
and euthanized bats using isoflurane followed by decapitation.
A sample of whole blood was immediately collected into 75 ml
heparinized capillary tubes. Blood samples were processed as
described above. The remaining carcass was dissected immedi-
ately and the wing tissue and lymph nodes stored in RNAlater.
Post-hibernation anti-Pd antibody titres were measured in tripli-
cate as described in bat capture and sampling protocols.
Infection status of individuals was confirmed with Pd-specific
qPCR [31] and by analysis of UV images. Fresh samples are
needed for RNA extraction and antibody titre measurements,
thus bats found dead prior to the end of the 16-week hibernation
period were not used for further analyses.
(d) RNA extraction and quantitative-PCR analysis
RNA fromwing and lymph node tissueswas extracted using RNA
isolation kits (Qiagen, Redwood, CA, USA) with an on-column
DNase I treatment (details provided in the electronic supplemen-
tary material, S1). PCR primers for the cytokine genes interleukin
6 (Il6) and the reference gene, ancient ubiquitous protein 1
(aup1), were designed based on the transcriptome assembly gener-
ated in [20]. Primers for interleukin 1b (Il1b), interleukin 4 (Il4),
interleukin 17A (Il17a) and interferon-g (ifng) transcripts were
designed based on M. lucifugus genome sequence (Ensembl).
Primer details and amplification efficiencies are reported in the
electronic supplementary material, S2. qPCR assays were run
on duplicates for each gene and sample on a LightCycler 96
instrument (Roche, Basel, Switzerland) with Fast Start Essential
DNA Green Master (Roche) (details provided in the electronic
supplementary material, S1).
(e) Data analyses
(i) Arousal frequency, scaled mass index and survival analyses
Arousals from torpor were determined for each individual using
temperature logger data with runlength encoding and a custom
function (ArousalFinder) in RSTUDIO v. 0.99.879 (R Core Team,
2015) as described in [34]. The date of death for each individual
was determined as the point of last arousal or, for survivors, as
the day of sampling after hibernation. Arousal frequency was
determined as the probability of bat arousal on a given day
post Pd-exposure (number of arousals/number of days between
first and last arousal) [34].
A scaled mass index (SMI; pre-hibernation¼mass  (mean
forearm length/forearm length)0.02029, post-hibernation ¼mass 
(mean forearm length/forearm length)0.1462) was calculated as
suggested in [35]. Differences in survival between groupswere esti-
mated with function Survfit in R based on Cox’s non-parametric
hazard model [36].
( f ) Statistical analyses
All analyses were conducted in R v. 3.2.1 (R Core Team,
2015). The differences in anti-Pd titres between September and
February within survivors were tested using paired, one-sided
Wilcoxon’s tests.
Differences in post-hibernation titre and mRNA level of log-
transformed Il6 and Il1b in the wing tissue and Il6, Il17a, Il1b and
Il4 in the lymph node tissue were analysed using analysis of var-
iance (ANOVA) in R. The main effects in the initial model for
post-hibernation titre included pre-hibernation titre (high and
low group), infection status (infected or control) and their
interaction. As covariates, we included the proportion of body
mass lost during hibernation (dSMI ¼ (pre-hibernation SMI 2
post-hibernation SMI)/pre-hibernation SMI), time to euthanasia
(i.e. minutes after removing the cage from the hibernation
chamber until euthanasia) and the interaction of each of the
covariates with the main effects. Proportion of SMI lost during
hibernation partially reflects water loss due to evaporation,
which was expected to increase plasma concentration of anti-Pd
antibodies. Time to euthanasia indicates the time that the bat
has spent at euthermic body temperature before euthanasia,
which was predicted to be reflected in the immune response.
We excluded the interactions of infection status and proportion
SMI lost as well as infection status and time to euthanasia from
the model because they were not significant. Tukey’s honestly
significant differences (HSD) test from package agricolae was
used for post hoc pairwise comparisons of post-hibernation
anti-Pd titres. We ran the test between infected and uninfected
rspb.royalsocietypublishing.org
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bats from low and high pre-hibernation titre groups, grouping
the individuals into four groups, because we found a significant
interaction of these effects in the ANOVA. The model included
the interactions of pre-hibernation titre and time to euthanasia,
and pre-hibernation titre and proportion SMI lost, as well as pro-
portion SMI lost and time to euthanasia, as in the initial ANOVA.
Because pre-hibernation titre was not associated with survi-
val, we only included the main effect of infection group in the
gene expression models. We predicted that the time to euthana-
sia could affect the activation of gene expression, but after we
found that neither it nor the interaction between time to euthana-
sia and infection group was significant in the models, we
excluded it from the models. Proportion SMI lost during hiber-
nation was included in all gene expression models, because it
had a significant effect on two of the genes. The interaction of
proportion SMI lost and infection was not significant in any
model, and was therefore excluded. We chose to use proportion
of SMI lost in the final models because it is more directly related
to fat consumed by the bat during the hibernation period than
the SMI after hibernation. The residuals of the ANOVAs con-
formed to a normal distribution based on qqplots, and had
non-significant heteroscedasticity based on the Fligner–Killeen
test. All ANOVAs were performed using function lm and type
II sums of squares were estimated using function ANOVA from
package car [37]. Significance was determined based on a of
0.05. When the covariates were significant in the model, we cal-
culated Pearson’s correlation coefficients between the covariate
and the dependent variable.
Alternative models for all variables were built using post-
hibernation SMI instead of proportion SMI lost as the covariate.
To ensure that potential cage effects did not bias our results, we
additionally analysed the post-hibernation titre and the log-
transformed gene expression values by maximum-likelihood
linear mixed models (lmer, package lme4) [38] treating cage as
the random effect. The results were visualized using R base
graphics and GGPLOT2 [39].
3. Results
To determine if pre-existing antibodies to Pd had an effect on
WNS survival, we comparedmortality rates during the captive
infection experiment. Infected bats had higher mortality than
control bats not exposed to Pd ( p ¼ 0.001; electronic sup-
plementary material, S3). The expected mortality of infected
bats was, on average, 2.2-fold higher than in the control bats
(95% confidence intervals 1.2 and 4.1). Neither pre-hibernation
SMI nor arousal frequency had a significant effect on the
observed mortality of infected or uninfected bats (table 1).
Next we examined how exposure to Pd influenced
anti-Pd antibody levels. Despite not affecting survival, anti-
Pd antibodies post-hibernation were significantly higher
than pre-hibernation in bats that survived hibernation in
all four experimental groups (Wilcoxon’s test, control low
p , 0.001, control high p ¼ 0.004, infected low p ¼ 0.017,
infected high p ¼ 0.016, figure 1). The 6.7+5.0-fold increase
in titre for bats not infected with Pd was presumably due to
physiological changes that occur during hibernation (dehy-
dration) or exposure to other fungal antigens. Titres were
highest after hibernation in infected bats that were assigned
to the high-titre group pre-hibernation (table 2, figure 1) and
increased 5.8+2.6-fold in this group. We also found a signifi-
cant interaction explaining post-hibernation antibody titres
between high/low-titre assignment and post-hibernation
time to euthanasia (table 2); antibody titres decreased in
high bats (both infected and control) the longer they were
aroused before euthanasia, but remained low in low bats. A
significant interaction explaining post-hibernation antibody
titres between high/low-titre assignment and proportion
body mass lost during hibernation was also found (table 2),
but the interaction between high/low-titre assignment and
post-hibernation body condition was not significant in the
alternative model (electronic supplementary material, S4).
Given that an antibody-mediated immune response does
not appear to be protective or pathological [22], we next
wanted to examine whether the local immune response in
the wing tissue is generating the expected response in the
regional lymph node. Expression was compared between
bats exposed to Pd and uninfected bats for five cytokines in
the wing tissue and the axillary lymph nodes. Of the five
cytokines (Il4, Il1b, Il17, Il6 and ifng) that we examined, we
Table 1. Details on the number of individuals (males /females) and mean+ standard deviation of body condition index (SMI), anti-Pd titres before and after
hibernation, and arousal frequency during hibernation, grouped by treatment and titre level before hibernation.
experimental
group N (M/F)
N survivors
(M/F) SMI pre-hib.
SMI post-
hib.
arousals
per day pre-hib. titre post-hib. titre
control low 11/12 6/9 10.22 (+0.89) 6.97 (+0.80) 0.21 (+0.05) 9.99 (+1.72) 13.33 (+4.75)
control high 13/11 3/5 10.20 (+1.03) 6.45 (+0.63) 0.23 (+0.07) 44.45 (+64.15) 21.37 (+12.20)
infected low 11/12 2/4 10.36 (+0.86) 7.04 (+1.06) 0.22 (+0.05) 9.81 (+2.00) 12.88 (+4.04)
infected high 13/12 2/6 10.09 (+0.87) 6.91 (+0.86) 0.23 (+0.06) 26.39 (+17.15) 67.66 (+62.11)
control
low
control
 high
infected
 low
infected
 high
0
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***
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c
Figure 1. Anti-Pd titres of M. lucifugus before hibernation (September) and
after hibernation (February). Asterisks indicate significant differences between
September and February titres within survivor bats ( paired Wilcoxon’s tests),
and letters indicate differences between groups in titres measured in February
(Tukey’s test). N ¼ 6–14 per group (survivors) and 23–25 per group (all
individuals.) *p ¼ 0.01–0.05, **p ¼ 0.001–0.05, ***p, 0.001. (Online
version in colour.)
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found increased expression in bats with WNS for Il6 in the
wing tissue and lymph node (figure 2a,b and table 2) and
for Il17a in the lymph nodes (figure 2c and table 2). We did
not find significant WNS-associated increases for the other
immunoregulatory cytokines that we examined, in either
the lymph nodes or the wing tissue.
To assess whether the elevated levels of inflammatory cyto-
kine gene expression that we observed might influence WNS
pathology, we determined whether cytokine gene expression
correlated with other physiological measurements, such as
hibernation behaviour. However, we found no statistically sig-
nificant difference in arousal frequency between treatment
and control groups, thus making the correlation with cytokine
expression uninformative. Previous hibernation experiments
of similar duration have also shown no differences in arousal
frequency between infected and uninfected bats [21]. We used
the proportion of SMI lost during hibernation as a measure of
a loss of body condition during hibernation [40]. We found a
significant negative correlation between wing tissue Il6 and
Il1b mRNA expression and proportion SMI lost during hiber-
nation (p ¼ 0.011 and 0.004; electronic supplementary
material, S5). In summary, a greater decline in mass during
hibernation (and, presumably, lower likelihood of survival)
correlated with lower Il6 and Il1b expression in the wing.
wing
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0
2
4
6
8
10
12
n
o
rm
al
iz
ed
 Il
6
n
o
rm
al
iz
ed
 Il
6
n
o
rm
al
iz
ed
 Il
17
A
*
lymph node
control infected
0
1
2
3
*
lymph node
control infected
0
2
4
6
8 **
(b)(a) (c)
Figure 2. Cytokine gene expression normalized to Aup1 and to the low-titre control group in control and infected bats. (a) Il6 expression in the wing tissue, N ¼ 21
(control) and 12 (infected), (b) Il6 and (c) Il17a mRNA expression in the axillary lymph nodes. N ¼ 16 (control Il6), 18 (control Il17a) and 12 (infected). *p ¼ 0.01–0.05,
**p ¼ 0.001–0.05. (Online version in colour.)
Table 2. Signiﬁcant effects for the post-hibernation titre and relative mRNA expression of cytokine genes with type II sums of squares. Estimates and standard
errors for the main effects were obtained from linear model using function lm in R. Full models and model selection in electronic supplementary material, S4.
*p ¼ 0.01–0.05; **p ¼ 0.001–0.05; ***p, 0.001.
response variable independent variables
type II sum
sq. d.f. F estimate+ s.e. Pr(>F )
February anti-Pd
titre
pre-hibernation titre (high versus low) 1204.76 1 59.08 1.68+ 14.23 6.36  1028***
infection 772.26 1 37.87 28.45+ 2.92 2.34  1026***
time to euthanasia 114.78 1 5.63 20.39+ 0.07 2.60  1022*
pre-hibernation titre (high versus
low)  Infection
1165.77 1 57.16 227.79+ 3.68 8.45  1028***
pre-hibernation titre (high versus
low)  Proportion SMI lost
132.51 1 6.50 285.54+ 33.56 1.76  1022*
pre-hibernation titre (high versus
low)  Time to euthanasia
574.26 1 28.16 0.41+ 0.08 1.92  1025***
residuals 489.45 24
interleukin-6, wing infection 4.72 1 6.50 0.77+ 0.3 1.60  1022*
proportion SMI lost 4.86 1 6.69 27.23+ 2.8 1.46  1022*
residuals 22.54 31
interleukin-1b, wing proportion SMI lost 3.58 1 9.36 25.73+ 1.87 4.54  1023**
residuals 11.87 31
interleukin-6, lymph
node
infection 1.65 1 4.68 0.50 + 0.24 4.02  1022*
residuals 8.81 25
interleukin 17A,
lymph node
infection 8.25 1 7.99 1.11+ 0.39 9.10  1023**
residuals 25.80 25
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We found a strong, negative correlation between
post-hibernation SMI and proportion SMI lost during
hibernation (Pearson’s r ¼ 20.72, t ¼ 25.9935, d.f. ¼ 33,
p-value ¼ 4.9  1027). Consequently, the results of models
using the former instead of the latter as a covariate produced
similar results for the gene expression models (electronic sup-
plementary material, S3). Thus, bat body condition at the end
of hibernation reflects the amount of body mass lost during
hibernation, and both correlate with cell-mediated immune
responses (table 2; electronic supplementary material, S6).
We also built alternative models including the replicate
cage as random effects, and found that the main effects of
linear mixed models agreed well with the linear models
(table 2; electronic supplementary material, S7).
4. Discussion
Our experiment elucidates the underlying immune respon-
ses of hibernating M. lucifugus to the fungal pathogen,
P. destructans. Owing to our previous observation of rela-
tively low anti-Pd antibody levels among European bats
resistant to WNS, we predicted higher mortality in bats
naive to Pd with higher pre-hibernation titres of antibodies
that were cross-reactive with Pd. However, we observed no
difference in survival between these groups. This experimen-
tally confirms that antibodies play no causative role in either
a protection or pathology in WNS, as previously suggested
by the lack of correlation found in wild bats [22]. We then
further examined transcription levels of Il17a, Il4, Il6, Il1b
and ifng to determine whether a T-cell response (Th17, Th2
or Th1) occurs during Pd infection in the winter. We found
that Pd infection induced the expression of Il6, an inflamma-
tory cytokine that can be associated with a Th17 response, in
the wing tissue. This observation is consistent with our pre-
vious transcriptomic study [20] and indicates that a local
inflammatory immune response occurs at the site of infection.
We also examined cytokine gene expression in the lymph
nodes that drained the infected tissue to determine if either
hibernation or Pd infection prevents the subsequent gener-
ation of a regional T-cell response. We found increased
expression of Il6 and Il17a in the axillary lymph nodes in
infected compared to uninfected bats, demonstrating the
initiation of a Th17 response. This observation reveals that
hibernation (i.e. torpor and arousals during overwintering)
does not prevent regional immune responses, although it
remains to be determined whether this response occurs
during torpor or is restricted to periodic euthermic arousals.
The results from our experiment indicate that both
humoral and cell-mediated immune responses to Pd occur
in M. lucifugus during hibernation, or at least during the per-
iodic arousals. Antibodies to Pd increased during infection
while the bats were hibernating, particularly in bats that
had higher antibody titres entering hibernation. This demon-
strates that B cells retain the ability to respond to infection in
bats while hibernating, similar to T-cell-independent B-cell
responses in hibernating 13-lined ground squirrels [29].
Hibernation also did not prevent the local inflammation
that led to the generation of a Th17 response in the draining
lymph nodes for the infected tissue. It is possible that the
increased arousal frequencies observed in some bats during
WNS [5,15] may be a misguided attempt to accelerate this
protective response. The resulting Th17 response could
even contribute to the disruption of torpor patterns observed
during WNS [15]. Unfortunately, our torpor arousal data for
this experiment cannot address this question because we did
not find significantly increased arousal frequencies either for
bats with high Il17 expression levels or Pd infection. Previous
studies have found that the increased arousal frequency is
most pronounced at the end of the hibernation period
[15,34]. In this study, the bats were taken out of hibernation
at the beginning of the last quartile of hibernation in order
to have enough individuals in each group for statistical analy-
sis, probably explaining the lack of difference in arousal rates
between infected and control bats.
We found that local inflammation at the site of infection,
represented by increased Il6 and Il1b expression, was prob-
ably protective as it was associated with lower decreases in
body condition. WNS may represent, in part, a protective
local inflammatory response that contributes to pathology
when the inflammation becomes systemic. The Th17 response
to Pd may also contribute to the inflammatory pathology that
is present upon emergence from hibernation [14]. Our results
indicate that M. lucifugus generates a Th17 response to Pd
during hibernation, similar to euthermic mammals infected
cutaneously with other fungi [27]. However, the response is
not able to clear the infection during hibernation and its
generation may lead to disruptions in thermoregulatory
behaviours that contribute to WNS mortality.
Adaptive immune responses to pathogenic fungi can pro-
vide sterilizing protection, lead to a chronic infection or cause
pathological inflammation [41]. The outcome is determined
by the type of effector T cells that are generated and varies
depending on the nature of the fungal pathogen. In our
prior study [20], only a single IL-17 family member was sig-
nificantly upregulated in the wing tissue in bats with WNS:
Il17c, which is produced by non-immune cells. The increased
expression of Il6, found in both studies, together with the
increased expression of other cytokines and chemokines
found in our transcriptomic study [22], is expected to initiate
a Th17 response that should recruit neutrophils to the site of
infection. Indeed, in the present study we found a significant
increase in lymph node levels of Il17a and Il6 mRNAs
between infected and uninfected bats, demonstrating that
this Th17 response has been initiated. In some instances,
fungal pathogens can prevent the formation of an appropri-
ate host response, as observed during infection by the
fungal pathogen causing chytridiomycosis in amphibians
[42]. However, this does not appear to occur during WNS,
at least by the same mechanism of suppressing the generation
of an appropriate immune response. We have found that gen-
eration of a Th17 immune response in the lymph node
probably occurs, and suggest the lack of neutrophils and
other leukocytes at the site of infection could be due to a
block, which is removed after emergence from hibernation.
The ecological effects of WNS, and whether species and
populations can persist, depends on the interplay between
the host, environment and pathogen. Interspecies and indi-
vidual preferences for hibernacula microclimates and winter
ecology dictate how effectively Pd is able to colonize bats
[31,34,43]. Infection severity depends on competing microbes
[44] and the initial defensive responses of the bat [20,22,45].
As shown in the current study, the type of host immune
response may determine whether the infection remains com-
mensal, as found in some European bat species, or becomes
pathological, as is typical in M. lucifugus and many other
rspb.royalsocietypublishing.org
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North American bat species. If lacking an appropriate
immune response, as described here, severe infection can
cause electrolyte depletion [46], evaporative water loss [18]
and other metabolic changes [19], which may lead to an
increase in arousal frequency. The increase in arousal fre-
quency caused by WNS explains 58% of the morbidity
associated with Pd infection due to depletion of fat stores
[15]. Even those bats that survive the full winter season are
faced with recovery from infection [47] and possibly a rapid
reversal of immune suppression in spring that appears to
cause immune reconstitution inflammatory syndrome [14].
These may delay the parturition of female bats and result in
lower body condition of both juveniles and females before
the subsequent hibernation, increasing the risk of WNS-
associated mortality in following years [48] and leading to an
extinction vortex. The results we present here contribute to
unravelling mechanisms causing WNS by describing the
activation of inflammatory pathways during the hiberna-
tion period. However, the relationships between different
contributing factors determine the ultimate outcome.
Here we assessed the function and importance of adaptive
immune responses during hibernation as a means of persist-
ence towards WNS in one of the most heavily impacted
species, M. lucifugus. We conclude that antibody responses
do not cause resistance or directly contribute to pathology,
but that other types of immune responses may be more protec-
tive. We showed that hibernation does not prevent the
amplification of antibody responses or the generation of a
Th17 response in bats. Furthermore, the stimulation of an inap-
propriate inflammatory immune response during hibernation
may negatively affect survival. The consequences of Pd infec-
tion on immune responses in each species should be taken
into consideration in planning of conservation measures [49].
Ethics. This study was carried out on bats from non-endangered
species in strict accordance with the recommendations in the
Guide for the Care and Use of Laboratory Animals of the National
Institutes of Health. All methods were approved by the Institutional
Animal Care and Use Committee at Bucknell University (protocol
DMR-016). The bats were collected under a State of Michigan
Scientific Collector’s Permit (SC 1475).
Data accessibility. Data available from Dryad Digital Repository: http://
dx.doi.org/10.5061/dryad.8m0k4 [50].
Authors’ contributions. T.M.L. sampled bats, did antibody and qPCR
assays, compiled data, ran statistics and wrote the manuscript.
J.M.P. sampled bats, did qPCR assays, ran statistics and contributed
to writing the manuscript. J.S.J., designed the study, collected bats,
did antibody assays and contributed to writing the manuscript.
E.J.R. sampled bats, compiled data, designed primers and contribu-
ted to writing the manuscript. S.G. tended to bats during
hibernation, downloaded data loggers and contributed to writing
the manuscript. A.K. collected bats and contributed to writing the
manuscript. D.M.R. designed the study, participated in the exper-
imental work and contributed to writing the manuscript. K.A.F.
designed the study, participated in the experimental work and
contributed to writing the manuscript.
Competing interests. We have no competing interests.
Funding. We thank US Fish and Wildlife Service (F14AP00739) and
Svenska Kulturfonden for the finance of this study.
Acknowledgements. We thank Cindy Rhone, Gretchen Long and the
rest of the animal care staff at Bucknell and Lasse Ruokolainen
(University of Helsinki) for the arousalFinder function.
References
1. Schrag SJ, Wiener P. 1995 Emerging infectious
disease: what are the relative roles of ecology and
evolution? Trends Ecol. Evol. 10, 319–324. (doi:10.
1016/S0169-5347(00)89118-1)
2. Scholthof K-BG. 2007 The disease triangle:
pathogens, the environment and society. Nat. Rev.
Microbiol. 5, 152–156. (doi:10.1038/nrmicro1596)
3. Coleman JTH, Reichard JD. 2014 Bat white-nose
syndrome in 2014: a brief assessment seven years
after discovery of a virulent fungal pathogen in
North America. Outlooks Pest Manag. 25, 374–377.
(doi:10.1564/v25_dec_08)
4. Lorch JM et al. 2011 Experimental infection of bats
with Geomyces destructans causes white-nose
syndrome. Nature 480, 376–378. (doi:10.1038/
nature10590)
5. Warnecke L, Turner JM, Bollinger TK, Lorch JM,
Misra V, Cryan PM, Wibbelt G, Blehert DS, Willis
CKR. 2012 Inoculation of bats with European
Geomyces destructans supports the novel pathogen
hypothesis for the origin of white-nose syndrome.
Proc. Natl Acad. Sci. USA 109, 6999–7003. (doi:10.
1073/pnas.1200374109)
6. Reeder DM, Moore MS. 2013 White-nose syndrome:
a deadly emerging infectious disease of hibernating
bats. In Bat evolution, ecology, and conservation
(eds RA Adams, SC Pedersen), pp. 413–434.
New York, NY: Springer.
7. Leopardi S, Blake D, Puechmaille SJ. 2015 White-
nose syndrome fungus introduced from Europe to
North America. Curr. Biol. 25, R217–R219. (doi:10.
1016/j.cub.2015.01.047)
8. Zukal J et al. 2016 White-nose syndrome without
borders: Pseudogymnoascus destructans infection
tolerated in Europe and Palearctic Asia but not in
North America. Sci. Rep. 6, 19829. (doi:10.1038/
srep19829)
9. Frick WF, Pollock JF, Hicks AC, Langwig KE, Reynolds
DS, Turner GG, Butchkoski CM, Kunz TH. 2010 An
emerging disease causes regional population
collapse of a common North American bat species.
Science 329, 679–682. (doi:10.1126/science.
1188594)
10. Garcia-Solache MA, Casadevall A. 2010 Global
warming will bring new fungal diseases for
mammals. mBio 1, e00061-10. (doi:10.1128/mBio.
00061-10)
11. Blehert DS et al. 2009 Bat white-nose syndrome: an
emerging fungal pathogen? Science 323, 227.
(doi:10.1126/science.1163874)
12. Bouma HR, Carey HV, Kroese FGM. 2010
Hibernation: the immune system at rest? J. Leukoc.
Biol. 88, 619–624. (doi:10.1189/jlb.0310174)
13. Wibbelt G et al. 2013 Skin lesions in European
hibernating bats associated with Geomyces
destructans, the etiologic agent of white-nose
syndrome. PLoS ONE 8, e74105. (doi:10.1371/
journal.pone.0074105)
14. Meteyer CU, Barber D, Mandl JN. 2012 Pathology in
euthermic bats with white nose syndrome suggests
a natural manifestation of immune reconstitution
inflammatory syndrome. Virulence 3, 583–588.
(doi:10.4161/viru.22330)
15. Reeder DM et al. 2012 Frequent arousal from
hibernation linked to severity of infection and
mortality in bats with white-nose syndrome. PLoS
ONE 7, e38920. (doi:10.1371/journal.pone.0038920)
16. Wilcox A, Warnecke L, Turner JM, McGuire LP,
Jameson JW, Misra V, Bollinger TC, Willis CKR. 2014
Behaviour of hibernating little brown bats
experimentally inoculated with the pathogen that
causes white-nose syndrome. Anim. Behav. 88,
157–164. (doi:10.1016/j.anbehav.2013.11.026)
17. Cryan PM, Meteyer CU, Boyles JG, Blehert DS. 2010
Wing pathology of white-nose syndrome in bats
suggests life-threatening disruption of physiology.
BMC Biol. 8, 135. (doi:10.1186/1741-7007-8-135)
18. Willis CKR, Menzies AK, Boyles JG, Wojciechowski
MS. 2011 Evaporative water loss is a plausible
explanation for mortality of bats from white-nose
syndrome. Integr. Comp. Biol. 51, 364–373.
(doi:10.1093/icb/icr076)
19. Verant ML, Meteyer CU, Speakman JR, Cryan PM,
Lorch JM, Blehert DS. 2014 White-nose syndrome
rspb.royalsocietypublishing.org
Proc.R.Soc.B
284:20162232
7
 on March 25, 2018http://rspb.royalsocietypublishing.org/Downloaded from 
initiates a cascade of physiologic disturbances in the
hibernating bat host. BMC Physiol. 14, 10. (doi:10.
1186/s12899-014-0010-4)
20. Field K, Johnson J, Lilley T, Reeder S, Rogers E, Behr M,
Reeder D. 2015 The white-nose syndrome
transcriptome: activation of anti-fungal host responses
in wing tissue of hibernating bats. PLoS Pathog. 11,
e1005168. (doi:10.1371/journal.ppat.1005168)
21. Brownlee-Bouboulis SA, Reeder DM. 2013 White-
nose syndrome-affected little brown myotis (Myotis
lucifugus) increase grooming and other active
behaviors during arousals from hibernation. J. Wildl.
Dis. 49, 850–859. (doi:10.7589/2012-10-242)
22. Johnson JS et al. 2015 Antibodies to
Pseudogymnoascus destructans are not sufficient for
protection against white-nose syndrome. Ecol. Evol.
5, 2203–2214. (doi:10.1002/ece3.1502)
23. Blanco JL, Garcia ME. 2008 Immune response to
fungal infections. Vet. Immunol. Immunopathol.
125, 47–70. (doi:10.1016/j.vetimm.2008.04.020)
24. Casadevall A, Pirofski L. 2012 Immunoglobulins in
defense, pathogenesis, and therapy of fungal
diseases. Cell Host Microbe 11, 447–456. (doi:10.
1016/j.chom.2012.04.004)
25. Zimmerman LM, Bowden RM, Vogel LA. 2014
A vertebrate cytokine primer for eco-immunologists.
Funct. Ecol. 28, 1061–1073. (doi:10.1111/1365-
2435.12273)
26. Lin L et al. 2009 Th1-Th17 cells mediate protective
adaptive immunity against Staphylococcus aureus
and Candida albicans infection in mice. PLoS Pathog.
5, e1000703. (doi:10.1371/journal.ppat.1000703)
27. Herna´ndez-Santos N, Gaffen SL. 2012 Th17 cells in
immunity to Candida albicans. Cell Host Microbe 11,
425–435. (doi:10.1016/j.chom.2012.04.008)
28. Vautier S, Sousa MdaG, Brown GD. 2010 C-type lectins,
fungi and Th17 responses. Cytokine Growth Factor Rev.
21, 405–412. (doi:10.1016/j.cytogfr.2010.10.001)
29. Bouma HR, Henning RH, Kroese FGM, Carey HV.
2013 Hibernation is associated with depression of
T-cell independent humoral immune responses in
the 13-lined ground squirrel. Dev. Comp. Immunol.
39, 154–160. (doi:10.1016/j.dci.2012.11.004)
30. Medzhitov R. 2007 Recognition of microorganisms
and activation of the immune response. Nature 449,
819–826. (doi:10.1038/nature06246)
31. Johnson JS et al. 2014 Host, pathogen, and
environmental characteristics predict white-nose
syndrome mortality in captive little brown myotis
(Myotis lucifugus). PLoS ONE 9, e112502. (doi:10.
1371/journal.pone.0112502)
32. Reeder DM, Widmaier EP. 2009 Hormone analysis in
bats. In Ecological and behavioral methods for
the study of bats (eds TH Kunz, S Parsons),
pp. 554–566. Baltimore, MD: Johns Hopkins
University Press.
33. Turner GG et al. 2014 Nonlethal screening of bat-
wing skin with the use of ultraviolet fluorescence to
detect lesions indicative of white-nose syndrome.
J. Wildl. Dis. 50, 566–573. (doi:10.7589/2014-
03-058)
34. Lilley TM, Johnson JS, Ruokolainen L, Rogers EJ,
Wilson CA, Schell SM, Field KA, Reeder DM. 2016
White-nose syndrome survivors do not exhibit
frequent arousals associated with
Pseudogymnoascus destructans infection. Front. Zool.
13, 12. (doi:10.1186/s12983-016-0143-3)
35. Peig J, Green AJ. 2009 New perspectives for
estimating body condition from mass/length data:
the scaled mass index as an alternative method.
Oikos 118, 1883–1891. (doi:10.1111/j.1600-0706.
2009.17643.x)
36. Therneau T, Lumley T. 2016 Survival analysis,
including penalized likelihood. See http://crantastic.
org/packages/survival/versions/17017.
37. Fox J, Weisberg S. 2011 An R companion to applied
regression. Beverley Hills, CA: Sage Publications.
38. Bates D, Ma¨chler M, Bolker B, Walker S. 2015 Fitting
linear mixed-effects models using lme4. J. Stat.
Softw. 67, 1–48. (doi:10.18637/jss.v067.i01)
39. Wickham H. 2010 ggplot2: elegant graphics for data
analysis, 1st edn. 2009. Corr. 3rd printing 2010
edition. New York, NY: Springer.
40. Jonasson KA, Willis CKR. 2011 Changes in body
condition of hibernating bats support the thrifty
female hypothesis and predict consequences for
populations with white-nose syndrome. PLoS ONE
6, e21061. (doi:10.1371/journal.pone.0021061)
41. Wu¨thrich M, Deepe GS, Klein B. 2012 Adaptive
immunity to fungi. Annu. Rev. Immunol. 30,
115–148. (doi:10.1146/annurev-immunol-020711-
074958)
42. Fites JS, Reinert LK, Chappell TM, Rollins-Smith LA.
2014 Inhibition of local immune responses by the
frog-killing fungus Batrachochytrium dendrobatidis.
Infect. Immun. 82, 4698–4706. (doi:10.1128/IAI.
02231-14)
43. Johnson JS, Lacki MJ, Thomas SC, Grider JF. 2012
Frequent arousals from winter torpor in
Rafinesque’s big-eared bat (Corynorhinus
rafinesquii). PLoS ONE 7, e49754. (doi:10.1371/
journal.pone.0049754)
44. Cornelison CT, Gabriel KT, Barlament C, Crow SA.
2014 Inhibition of Pseudogymnoascus destructans
growth from conidia and mycelial extension by
bacterially produced volatile organic compounds.
Mycopathologia 177, 1–10. (doi:10.1007/s11046-
013-9716-2)
45. Moore MS, Reichard JD, Murtha TD, Nabhan ML,
Pian RE, Ferreira JS, Kunz TH. 2013 Hibernating
little brown myotis (Myotis lucifugus) show variable
immunological responses to white-nose syndrome.
PLoS ONE 8, e58976. (doi:10.1371/journal.pone.
0058976)
46. Cryan PM et al. 2013 Electrolyte depletion in white-
nose syndrome bats. J. Wildl. Dis. 49, 398–402.
(doi:10.7589/2012-04-121)
47. Fuller NW, Reichard JD, Nabhan ML, Fellows SR,
Pepin LC, Kunz TH. 2011 Free-ranging little brown
myotis (Myotis lucifugus) heal from wing damage
associated with white-nose syndrome. EcoHealth 8,
154–162. (doi:10.1007/s10393-011-0705-y)
48. Frick WF, Reynolds DS, Kunz TH. 2010 Influence of
climate and reproductive timing on demography of
little brown myotis Myotis lucifugus. J. Anim. Ecol.
79, 128–136. (doi:10.1111/j.1365-2656.2009.
01615.x)
49. Reeder DM, Field KA, Slater MH. 2016 Balancing the
costs of wildlife research with the benefits of
understanding a panzootic disease, white-nose
syndrome. ILAR J. 56, 275–282. (doi:10.1093/ilar/
ilv035)
50. Lilley TM, Prokkola JM, Johnson JS, Rogers EJ,
Gronsky S, Kurta A, Reeder DM, Field KA. 2017 Data
from: Immune responses in hibernating little brown
myotis (Myotis lucifugus) with white-nose
syndrome. Dryad Digital Repository. (doi:10.5061/
dryad.8m0k4)
rspb.royalsocietypublishing.org
Proc.R.Soc.B
284:20162232
8
 on March 25, 2018http://rspb.royalsocietypublishing.org/Downloaded from 
